Pneomococcal Vaccine Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

A Study to Learn About the Safety and Immune Response of 20vPnC in Adults in India.
Condition:   Pneumococcal Disease Intervention:   Biological: 20-valent pneumococcal conjugate vaccine Sponsor:   Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 25, 2023 Category: Research Source Type: clinical trials

Safety, Tolerability, and Immunogenicity of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Healthy Infants
Condition:   Pneumococcal Vaccines Interventions:   Biological: 0.5 ml dose of 1.1 mcg VAX-24;   Biological: 0.5 ml dose of PCV15;   Biological: 0.5 ml dose of 2.2 mcg VAX-24;   Biological: 0.5 ml dose of 2.2/4.4 mcg VAX-24 Sponsor:   Vaxcyte, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 6, 2023 Category: Research Source Type: clinical trials